Upcoming FDA calendar events
Date as reportedDrug and companyEventSource
30 Nov 2026 bezuclastinibCogent Biosciences, Inc. (COGT) Company-disclosed PDUFA goal dateAnnounced review target Original source
22 Dec 2026 LorundrostatMineralys Therapeutics Inc. (MLYS) Company-disclosed PDUFA goal dateAnnounced review target Original source
22 Dec 2026 LorundrostatMineralys Therapeutics Inc. (MLYS) Company-disclosed PDUFA goal dateAnnounced review target Original source
30 Dec 2026 bezuclastinibCogent Biosciences, Inc. (COGT) Company-disclosed PDUFA goal dateAnnounced review target Original source
30 Dec 2026 bezuclastinibCogent Biosciences, Inc. (COGT) Company-disclosed PDUFA goal dateAnnounced review target Original source
1 Feb 2027 MitapivatAgios Pharmaceuticals, Inc. (AGIO) Company-disclosed PDUFA goal dateAnnounced review target Original source
1 Feb 2027 MitapivatAgios Pharmaceuticals, Inc. (AGIO) Company-disclosed PDUFA goal dateAnnounced review target Original source
1 Feb 2027 MitapivatAgios Pharmaceuticals, Inc. (AGIO) Company-disclosed PDUFA goal dateAnnounced review target Original source
12 Feb 2027 TinlarebantBelite Bio, Inc (BLTE) Company-disclosed PDUFA goal dateAnnounced review target Original source
12 Feb 2027 TinlarebantBelite Bio, Inc (BLTE) Company-disclosed PDUFA goal dateAnnounced review target Original source

FDA calendar by TrialRedline